Balulao, Vaniessa Mea B.
HRN: 21-53-05 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/16/2022
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
08/16/2022
08/22/2022
IVTT
540mg
Q8 For 7 Days
Pneumonia
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes